In Brief: First Medical, Inc.
This article was originally published in The Gray Sheet
First Medical, Inc.: Walter Narajowski is named president and CEO. Narajowski formerly served as VP and general manager of the Abbott Hospital Product Division's infusion pumps and critical care products businesses. Former President and CEO David McCaslin left last summer by mutual agreement with the board, the company explains. First Medical also announces the submission in December of a 510(k) submission to FDA for its Alpha Dx clinical decision support system. The device uses whole blood "for the rapid, quantitative and simultaneous measurement of a panel of tests," including myoglobin, CK, CK-MB, relative index and troponin I, "to aid in the diagnosis of acute myocardial infarction"...
You may also be interested in...
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.